---
# System prepended metadata

title: Analgesics market to grow at a CAGR of 4.9% during the forecast period

---

# Analgesics market to grow at a CAGR of 4.9% during the forecast period
![](https://i.imgur.com/z1p46Vc.jpg)

According to Next Move Strategy Consulting, the global **[Analgesics Market](https://www.nextmsc.com/report/analgesics-market)** size was valued at USD 35.03 million in 2021 and is expected to reach USD 56.86 million by 2030, at a CAGR of 4.9% during the forecast period 2022–2030. 

Factors such as rising incidences of chronic diseases such as tuberculosis and a substantial rise in the number of patients suffering from infectious diseases such as gastrointestinal and respiratory diseases are driving the demand for painkillers. In addition, there has been a rapid increase in the demand for over-the-counter analgesics due to an increase in the number of arthritis patients.

However, factors such as drug abuse, growing use of biologics for the treatment of inflammatory pain, and stringent regulatory policies for the use of painkillers are expected to restrain the growth of the analgesics market during the forecast period. 
On the contrary, the development of novel selective mechanisms arising from a mechanism of existing analgesic drugs is expected to create ample growth opportunities for the analgesics market in the upcoming years.

**Request a sample here: https://www.nextmsc.com/analgesics-market/request-sample**

Based on type, the analgesics market is divided into non-opioid and opioid. Based on route of administration, it is segmented into oral route, intravenous route, rectal route, transdermal route, and topical route. Region-wise, the global analgesics market is analyzed across North America, Europe, Asia-Pacific, and RoW.

**Inquire before buying: https://www.nextmsc.com/analgesics-market/inquire-before-buying**

North America has been the leading consumer of analgesics due to the prevalence of osteoarthritis, cancer, and cardiovascular diseases, followed by the Europe region. The Europe region is expected to witness increasing consumption of analgesics in the coming years due to the growing prevalence of arthritis and several other bone-related conditions.

In addition, growing prevalence of fever increases the use of paracetamol, which in turn drives the growth of the analgesics market.

**Avail customization in reports: https://www.nextmsc.com/**

The report offers an extensive analysis of competitive landscape of the global analgesics market. Some of the major market players in the manufacturing of analgesics are Abbott Laboratories, Bayer AG, Glaxosmithkline plc, Johnson and Johnson, Pfizer Inc, Novartis AG, Teva Pharmaceuticals, Sanofi SA, ABBVIE INC., and Sun Pharma.

**Related Reports**:
•	[Anesthesia CO2 Absorbent Market](https://www.nextmsc.com/report/anesthesia-co2-absorbent-market)
•	[Alopecia Market](https://www.nextmsc.com/report/alopecia-market)
•	[Ceramide Market](https://www.nextmsc.com/report/ceramide-market)

**About Us**:
Next Move Strategy Consulting is an independent and trusted third-platform market intelligence provider, committed to deliver high quality, market research reports that help multinational companies to triumph over their competitions and increase industry footprint by capturing greater market share. Our research model is a unique collaboration of primary research, secondary research, data mining and data analytics. 

We have been servicing over 1000 customers globally that includes 90% of the Fortune 500 companies over a decade. Our analysts are constantly tracking various high growth markets and identifying hidden opportunities in each sector or the industry. We provide one of the industry’s best quality syndicate as well as custom research reports across 10 different industry verticals. We are committed to deliver high quality research solutions in accordance to your business needs. Our industry standard delivery solutions that range from the pre consultation to after-sales services, provide an excellent client experience and ensure right strategic decision making for businesses.
